Criteria for use of dinoprostone intracervical gel for cervical ripening.
Mancano
M A
MA
Department of Pharmacy, Temple University Hospital, Philadelphia, PA 19140, USA.
D002584:Cervix Uteri / Q000187:drug effects*; D015232:Dinoprostone / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D005260:Female; D005782:Gels; D006801:Humans; D007751:Labor, Induced / Q000379:methods*; D011247:Pregnancy; D011256:Pregnancy Outcome
D005782:Gels; D015232:Dinoprostone